In neurodegenerative diseases, an increase rather than a decrease in SOD2 is often observed, which has been interpreted as a compensatory mechanism aiming to counterbalance the increased mitochondrial superoxide production [46]. Here, SOD2 is linked to neurodegenerative disease.